Venor Pharma Limited Digoxin Export Data — India (DGFT 2022–2026)

Name: Venor Pharma Limited Digoxin Export Records India — #5 Exporter, 7 Shipments, $67.5K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Digoxin

India Pharmaceutical Trade Intelligence

$2.2M203 Suppliers104 CountriesHS 30049099

ExportsIndia → UNITED STATES51.4%India → SRI LANKA5.7%

ImportsGERMANY → India$83.2K UNITED STATES → India$12.2K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: NORTHSTAR DISTRIBUTION

Venor Pharma Limited — Digoxin Exporter #5 | $67.5K Trade Value | TransData Nexus | TransData Nexus

Venor Pharma Limited — Digoxin Exporter Profile

Indian Pharmaceutical Exporter · #5 for Digoxin · $67.5K export value · DGFT Verified

Venor Pharma Limited is the #5 Indian exporter of Digoxin with $67.5K in export value and 7 verified shipments. Venor Pharma Limited holds a 3.1% market share in Digoxin exports across 6 countries. The company exports 9 pharmaceutical products worth $8.6M across 4 therapeutic categories.

Venor Pharma Limited — Digoxin Export Profile: Buyers & Destinations

Venor Pharma Limited Digoxin export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Digoxin?

Country	Value	Shipments	Share
UNITED STATES	$1.1M	69	58.9%
SRI LANKA	$124.7K	16	6.6%
VENEZUELA	$115.9K	29	6.1%
CANADA	$95.5K	8	5.0%

Who Are the Top Buyers of Digoxin from India?

Buyer	Country	Value	Orders
NORTHSTAR DISTRIBUTION CENTER 8912	UNITED STATES	$597.5K	20
SUN PHARMACEUTICAL INDUSTRIES,INC.	UNITED STATES	$259.1K	19
SUN PHARMACEUTICAL INDUSTRIES INC	UNITED STATES	$124.8K	17
JAMP PHARMA CORPORATION	CANADA	$72.7K	4
NORTHSTAR DISTRIBUTION CENTER	UNITED STATES	$57.1K	2
SUN PHARMACEUTICAL INDUSTRIESINC.	UNITED STATES	$54.5K	3
F.D.E.C.A	ECUADOR	$38.7K	2
GREAT TIMEC PHARMA COMPANY LIMITED	NIGERIA	$28.2K	4
LEBOO HEALTHCARE PRODUCTS C.A	VENEZUELA	$26.2K	6
ACTIVO INGREDINETS PTE LTD.	SINGAPORE	$25.9K	5

India's Digoxin is purchased by 293 buyers worldwide. The top buyer is NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES), followed by SUN PHARMACEUTICAL INDUSTRIES,INC. and SUN PHARMACEUTICAL INDUSTRIES INC.

How Does Venor Pharma Limited Compare to Nearest Digoxin Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	UNICURE REMEDIES PRIVATE LIMITED	$82.0K	21	6	$3.9K
4	ACME GENERICS LLP	$72.7K	4	1	$18.2K
5	VENOR PHARMA LIMITED ★	$67.5K	7	6	$9.6K
6	CARITAS HEALTHCARE PRIVATE LIMITED	$66.7K	3	1	$22.2K
7	SWISS PARENTERALS LIMITED	$46.2K	8	3	$5.8K

Venor Pharma Limited ranks #5 among 203 Indian Digoxin exporters. Average shipment value of $9.6K compared to the market average of $8.0K. The closest competitors by value are UNICURE REMEDIES PRIVATE LIMITED and ACME GENERICS LLP.

Which Indian Ports Ship Digoxin Exports?

Port	Shipments	% Share
SAHAR AIR	206	23.3%
SAHAR AIR CARGO ACC (INBOM4)	167	18.8%
NHAVA SHEVA SEA (INNSA1)	66	7.4%
DELHI AIR CARGO ACC (INDEL4)	57	6.4%
Bombay Air	56	6.3%
DELHI AIR	47	5.3%
AHEMDABAD AIR ACC (INAMD4)	27	3.0%
JNPT	23	2.6%

Geopolitical & Trade Policy Impact on Venor Pharma Limited's Digoxin Exports

Recent geopolitical developments have introduced significant challenges for Indian pharmaceutical exporters like Venor Pharma. The escalation of conflicts in the Middle East, particularly the Red Sea crisis, has led to disruptions in key shipping routes. Major carriers have suspended or restricted transits through the Strait of Hormuz and the Red Sea–Suez Canal corridor, resulting in extended transit times by 10–20 days and increased freight rates by 40–50% on India–Europe routes. (livemint.com) These disruptions are particularly concerning for time-sensitive pharmaceutical shipments, potentially affecting the timely delivery of products like Diazepam and Fentanyl.

In the United States, recent trade policies have introduced additional complexities. The imposition of a 25% reciprocal tariff on Indian imports, effective August 2025, and the subsequent increase to a 50% tariff linked to India's energy trade decisions, have raised concerns about the cost competitiveness of Indian pharmaceutical products in the U.S. market. (en.wikipedia.org) While pharmaceuticals have been largely exempt from these tariffs, the potential for future policy shifts necessitates vigilance.

The European Union's implementation of the Falsified Medicines Directive (FMD) has also impacted Indian exporters. Compliance with stringent serialization and traceability requirements has increased operational costs. For companies like Venor Pharma, ensuring adherence to these regulations is crucial to maintain market access and competitiveness in the EU.

Venor Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA, WHO, and EU authorities enforcing stringent Good Manufacturing Practice (GMP) standards. Instances such as the FDA's warning letter and import alert issued to Viatris' facility in Indore, India, in December 2024, highlight the critical importance of compliance. (en.wikipedia.org) For Venor Pharma, maintaining impeccable quality standards and regulatory compliance is essential to avoid similar setbacks and to sustain its export operations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Digoxin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Venor Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 104+ countries, 293+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Digoxin

Digoxin

Venor Pharma Limited — Digoxin Exporter Profile

Venor Pharma Limited — Digoxin Export Profile: Buyers & Destinations

Where Does India Export Digoxin?

Who Are the Top Buyers of Digoxin from India?

What Is India's Total Digoxin Export Value and How Much Does Venor Pharma Limited Contribute?

What Is the Average Shipment Value for Venor Pharma Limited's Digoxin Exports?

How Does Venor Pharma Limited Compare to Other Indian Digoxin Exporters?

Regulatory Requirements: Exporting Digoxin to Key Markets

United States — FDA

Canada — HC

How Does Venor Pharma Limited Compare to Nearest Digoxin Exporters?

Which Indian Ports Ship Digoxin Exports?

What Other Cardiovascular Products Does Venor Pharma Limited Export?

Geopolitical & Trade Policy Impact on Venor Pharma Limited's Digoxin Exports

Venor Pharma Limited — Regulatory Compliance & Quality Standards

About Venor Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Digoxin Export Data from Venor Pharma Limited

Digoxin Stats

Company Overview

Top Products by Venor Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source